Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
It is common for the body to first adjust to the treatment before significant weight loss begins
GLP-1 agonists are generally safe and well-tolerated, but ongoing monitoring ensures any issues are identified and managed promptly, optimising both your diabetes control and cardiovascular health
Moreover, healthcare costs account for only 25% of the total societal costs of obesity, with significant losses in productivity and health-related quality of life
Patients benefit most when medication is paired with broader lifestyle restructuring
doi: 10.1038/mp.2016.44 Summary Keywords depression, glucagon-like peptide-1 (GLP-1), neuroinflammation, neurogenesis, synaptic plasticity Citation Kim Y-K, Kim OY and Song J (2020) Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
US$ 28.67
US$ 25.00
US$ 22.23
US$ 21.38
US$ 25.28
